Anebulo Pharmaceuticals, Inc. (ANEB)

Anebulo Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	15	3.09	11.25	14.55	19.99	3.02
Cash & Short-Term Investments	15	3.09	11.25	14.55	19.99	3.02
Cash Growth	125.73%	-72.49%	-22.69%	-27.21%	560.69%	-
Other Receivables	0.03	-	-	-	-	0
Receivables	0.03	-	-	-	-	0
Prepaid Expenses	0.37	0.41	0.42	1.03	1.67	-
Total Current Assets	15.4	3.51	11.67	15.58	21.65	3.03
Other Long-Term Assets	0.45	0.57	-	-	-	-
Total Assets	15.84	4.07	11.67	15.58	21.65	3.03
Accounts Payable	0.32	0.16	0.53	0.38	0.11	-
Accrued Expenses	0.56	0.1	0.53	0.13	0.13	0.02
Short-Term Debt	-	-	-	-	-	0.2
Total Current Liabilities	0.88	0.26	1.07	0.51	0.24	0.22
Total Liabilities	0.88	0.26	1.07	0.51	0.24	0.22
Common Stock	0.04	0.03	0.03	0.02	0.02	0.01
Additional Paid-In Capital	84.99	69.19	67.78	60.51	60.03	-
Retained Earnings	-70.07	-65.4	-57.2	-45.47	-38.64	-0.18
Total Common Equity	14.96	3.81	10.6	15.07	21.41	-0.17
Shareholders' Equity	14.96	3.81	10.6	15.07	21.41	2.8
Total Liabilities & Equity	15.84	4.07	11.67	15.58	21.65	3.03
Total Debt	-	-	-	-	-	0.2
Net Cash (Debt)	15	3.09	11.25	14.55	19.99	2.82
Net Cash Growth	125.73%	-72.49%	-22.69%	-27.21%	607.78%	-
Net Cash Per Share	0.57	0.12	0.45	0.62	1.47	0.24
Filing Date Shares Outstanding	41.08	25.93	25.63	23.37	23.34	12
Total Common Shares Outstanding	41.08	25.93	25.63	23.34	23.34	12
Working Capital	14.52	3.25	10.6	15.07	21.41	2.8
Book Value Per Share	0.36	0.15	0.41	0.65	0.92	-0.01
Tangible Book Value	14.96	3.81	10.6	15.07	21.41	-0.17
Tangible Book Value Per Share	0.36	0.15	0.41	0.65	0.92	-0.01

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q